Despite the apparent anecdotal basis of the FDA warning cannot be dismissed. If you consider having or performing the CCSVI procedure safety must be the primary concern. The literature demonstrated that pre-procedure imaging improves the safety and reduces the duration of many procedures. MRV is unparalleled in is ability to provide a venous roadmap before a CCSVI procedure. High quality imaging also contributes to safety during the procedure. Intravascular ultrasound (IVUS) provides the most detailed intra-procedure images.
We are of the opinion that if the CCSVI procedure is going to be performed with maximal safety in mind the treating physician must know the anatomy beforehand. This is best accomplished with an MRV. In an effort to ensure utmost patient safety all patients undergoing the CCSVI procedure at Synergy will have a pre-procedure MRV and have intra-procedure IVUS.
The claim is that preprocedure imaging provides a roadmap and improves safety. The preprocedure imaging of an MRV comes at a cost to the patient of about $2000. The doctor states that preprocedure imaging improves safety in other diseases. I wonder if these other diseases are venous diseases, and if the proprocedure imaging of choice is an MRV? Does a person getting treated for Budd Chairi or Superior Vena Cava syndrome get an MRV first? Even if they do, is it for diagnostic purposes or is it for information to use during the procedure?
MarkW, you can add Synergy to the list now of doctors using IVUS in every procedure.